PHARMA

Dr. Agarwals Health Care shares gain attention as regulatory disclosure for Claymore Investments received

By Ali Abbas Najmi •
Claymore Investments (Mauritius) Pte Ltd filed a disclosure under SEBIs Substantial Acquisition of Shares and Takeovers Regulations, 29(2), with Dr. Agarwals Health Care Ltd on August 13, 2026.

Why did Dr. Agarwals Health Care Ltd shares fall today?

Shares of Dr. Agarwals Health Care Ltd declined today, closing at ₹506.1 with a fall of 0.43%. The dip occurred on Friday, and market watchers point to a regulatory filing as the likely trigger for this negative movement. The stock’s price reacted to news that a major foreign investor was reducing its stake in the company.

The key development was a disclosure submitted to the stock exchanges under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing confirmed that Claymore Investments (Mauritius) Pte. Ltd., along with a person acting in concert, was involved in a sale of shares of the company. While such disclosures are a standard regulatory requirement for substantial transactions, they often signal to the market that a large institutional investor is booking profits or adjusting its portfolio.

News of a significant shareholder selling a portion of its holdings typically creates short-term selling pressure. Investors may interpret the move as a lack of confidence from a sophisticated player or simply a reason to lock in gains, leading to a rise in supply of the stock on the exchange. Consequently, the share price faced downward pressure for the session, resulting in the modest but noticeable decline.

What does Dr. Agarwals Health Care Ltd do?

Dr. Agarwals Health Care Limited is a publicly listed company with shares traded on the BSE Limited and the National Stock Exchange of India Limited. It maintains a registered corporate office at 6th Floor, Menon Eternity, 1st Main Road, Austin Nagar, Alwarpet, in Chennai, Tamil Nadu. The company is subject to regulations set by the Securities and Exchange Board of India (SEBI), specifically regarding disclosures for substantial acquisitions of shares and takeovers.

As a listed entity, Dr. Agarwals Health Care Limited is the subject of formal disclosures to stock exchanges. Such disclosures are required under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, concerning significant transactions in the company's shares, such as their sale by major investors.

Dr. Agarwals Health Care Ltd Financials

In Crores
564
40
Mar 2026
614
45
Jun 2026
Revenue
Net Profit

Dr. Agarwals Health Care Ltd. reported a sequential quarter-over-quarter growth in its financial performance. Revenue increased from ₹564.11 Crores in March 2026 to ₹614.02 Crores in June 2026, representing a growth of approximately 8.85%. Concurrently, net profit also rose from ₹39.71 Crores to ₹45.23 Crores over the same period, indicating a quarterly profit growth of about 13.9%. These figures demonstrate a positive upward trend in both top-line revenue and bottom-line profitability for the company during the first quarter of the 2026-27 financial year compared to the preceding quarter.

Dr. Agarwals Health Care Ltd Shareholding Pattern

Holdings
Promoter
32.34%
FIIs
57.97%
DIIs
7.72%
Public
1.97%

Promoter holding stands at 32.34% of the total share capital. Foreign Institutional Investors (FIIs) hold 57.97% stake in the company, while Domestic Institutional Investors (DIIs) hold 7.72%. Public shareholders hold the remaining 1.97% stake in Dr. Agarwals Health Care Ltd.

Dr. Agarwals Health Care Ltd FAQs

Q: Why did Dr. shares fall 0.43% today?

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte Ltd. This corporate action caught investor attention, leading to increased trading activity in the stock.

Q: What is the shareholding pattern of Dr. Agarwals Health Care Ltd?

As per the latest data, promoters hold 32.34% stake in Dr. Agarwals Health Care Ltd, while FII holding stands at 57.97%. Domestic institutional investors hold 7.72%, and public shareholders account for 1.97% of the equity.

Q: What is the current stock price of Dr. Agarwals Health Care Ltd?

Dr. Agarwals Health Care Ltd shares are currently trading at ₹506.1, recording a decline of 0.43% from the previous close.

Q: What is the market capitalization of Dr. Agarwals Health Care Ltd?

The company currently has a market capitalization of ₹16044.7 crore, reflecting its valuation in the Indian equity market.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. The stock prices mentioned are as of the time of writing. Ali Abbas Najmi and the publisher do not hold any positions in the stocks mentioned. Please consult a SEBI-registered financial advisor before making any investment decisions.